Evidence map›Paper›PMID 41672736›Full record

ArticleGenes & development2026

Chromatin binding and N-terminal domains of DNMT3B1 confer specificity for developmentally regulated CpG island methylation.

Komal Yasmin, Tatyana B Nesterova, Neil Brockdorff

Abstract read
In one paragraph

Article in Genes & development, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Komal YasminDepartment of Biochemistry, University of Oxford, Oxford OX1 3QU, United Kingdom.
Tatyana B NesterovaDepartment of Biochemistry, University of Oxford, Oxford OX1 3QU, United Kingdom.ORCID 0000-0001-7740-4386
Neil BrockdorffDepartment of Biochemistry, University of Oxford, Oxford OX1 3QU, United Kingdom neil.brockdorff@bioch.ox.ac.uk.ORCID 0000-0003-4838-2653

Funding

Wellcome Trust 215109Wellcome Trust 215513
6 · The paper itself

Abstract

CpG methylation in mammalian genomes is established by the closely related de novo DNA methyltransferases DNMT3A and DNMT3B. While both enzymes contribute to genome-wide CpG methylation, DNMT3B has a unique role in developmentally regulated CpG island (CGI) methylation on the inactive X chromosome and at other sites in the genome. The mechanistic basis for this specificity is poorly understood. Here we have developed an in vitro embryonic stem cell model system to dissect critical determinants of DNMT3B specificity. Our model faithfully recapitulates developmentally regulated CGI methylation and additionally provides novel insights into CpG methylation at

Indexed as

ChromatinCpG IslandsDNA (Cytosine-5-)-MethyltransferasesDNA MethylationGene Expression Regulation, DevelopmentalAnimalsDNA Methyltransferase 3BEmbryonic Stem CellsMiceProtein BindingProtein DomainsChromatinDNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3BchromatinCpG islandDNA methylationepigeneticsX inactivation

Identifiers

PMID41672736
PMCPMC13138329

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.